← Open Payments lookup

PETER HAUSMAN: Open Payments

NPI 1497234892 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,412 in 71 payments from 10 companies in 2025. Trend: 2023 $299 · 2024 $333 · 2025 $1,412

Food & beverage: $1,300Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.13$335
Lundbeck LLC14$312
Otsuka America Pharmaceutical, Inc.10$176
E.R. Squibb & Sons, L.L.C.9$151
ABBVIE INC.14$147
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$88
Alkermes, Inc.3$82
Neurocrine BioSciences, Inc.2$57
Janssen Pharmaceuticals, Inc2$39
Vanda Pharmaceuticals Inc.1$24

Products named: REXULTI, COBENFY, VRAYLAR, AUSTEDO XR, ABILIFY MAINTENA, CAPLYTA, ARISTADA, INGREZZA.

Industry payments across WA — which companies pay providers there.